| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/24/1991 | CN1012434B Improvements in or relating to leukotriene antagonists |
| 04/24/1991 | CA2070416A1 Polypeptide inhibitors of gamma interferon |
| 04/23/1991 | US5010095 N-(W-substituted alkyl)-'-(imidazol-4-yl)alkyl)guanidine |
| 04/23/1991 | US5010084 Antihistamines; asthma |
| 04/23/1991 | US5010058 Antinflammatory agents, autoimmune diseases, lupus |
| 04/23/1991 | CA1283419C Substituted di-t-butylphenols |
| 04/22/1991 | CA2028042A1 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
| 04/21/1991 | CA2028076A1 Synthesis of swainsonine and analogs thereof |
| 04/20/1991 | WO1991006005A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
| 04/18/1991 | WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 04/18/1991 | WO1991005046A1 Granulocyte-colony stimulating factor receptors |
| 04/18/1991 | WO1991004749A1 Method of treating infectious bursal disease virus |
| 04/18/1991 | WO1991002805A3 Recombinant retroviruses delivering vector constructs to target cells |
| 04/18/1991 | WO1990015076A3 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
| 04/18/1991 | DE3933850A1 Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins Cytolysis inhibitor (ZLI), these a blood plasma protein encoding DNA sequence, and a plasmid, a host organism and a method for obtaining this protein |
| 04/17/1991 | EP0423077A1 Tripeptide compounds and their pharmaceutical use as immunomodulators |
| 04/17/1991 | EP0422566A1 A process for the preparation of 3-(L-pyroglutamyl)-L-thiazolidine-4-carboxylic acid derivatives |
| 04/17/1991 | EP0422329A1 Substituted dibenzofurans and methods of using same |
| 04/17/1991 | EP0422328A2 Substituted isoquinolines and their use |
| 04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| 04/17/1991 | EP0422097A1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo. |
| 04/17/1991 | EP0422051A1 Condensed pyrazole 3-oxo-propanenitrile derivatives and process for their preparation |
| 04/17/1991 | CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells |
| 04/17/1991 | CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent |
| 04/17/1991 | CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells |
| 04/16/1991 | US5008374 IL-1α derivatives and drugs |
| 04/16/1991 | US5008268 2-aminopyrimidinone derivatives |
| 04/16/1991 | US5008263 Diazepine antiallergy agents |
| 04/16/1991 | US5008246 Novel peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same |
| 04/16/1991 | US5008240 Polypeptide with amino acid sequence of cartilage inducing factor A or B |
| 04/16/1991 | CA1283103C Substituted 2,3-dihydro-6-hydroxy-pyrimido ¬2,1-f|-purine- 4,8(1h,9h)-diones |
| 04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |
| 04/14/1991 | CA2027169A1 Chemical compounds |
| 04/11/1991 | DE4029747A1 Psoriasis treatment |
| 04/10/1991 | EP0421949A1 Chemically modified allergens and process for the preparation thereof |
| 04/10/1991 | EP0421587A2 Xanthine derivatives used in asthma |
| 04/10/1991 | EP0421074A1 Pharmacologically active peptides and pharmaceutical preparations containing them |
| 04/10/1991 | EP0420849A1 Use of sucralfate |
| 04/10/1991 | CN1050503A Stabilized leukocyte-interferons |
| 04/09/1991 | US5006548 Hyaluronidase inhibitors, antiallergens, immunomodulators |
| 04/09/1991 | US5006515 Immunology disorders, antitumor agent |
| 04/09/1991 | US5006337 For treating skin disorders |
| 04/09/1991 | CA1282779C Polysaccharide ron substance, production of the same and use of the same |
| 04/07/1991 | WO1991005043A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins |
| 04/07/1991 | CA2042605A1 Cytolysis inhibitor proteins (cli), dna sequences coding for said proteins, and plasmids, host organisms, and processes for obtaining said proteins |
| 04/04/1991 | WO1991004272A1 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/04/1991 | WO1991004055A1 Treatment of autoimmune disease |
| 04/04/1991 | WO1991004053A1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells |
| 04/04/1991 | WO1991004051A1 Peptides including ctl epitopes of hiv proteins and use thereof |
| 04/04/1991 | WO1991004030A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 04/04/1991 | WO1991004023A1 Isolating aminoarginine and use to block nitric oxide formation in body |
| 04/04/1991 | WO1991001744A3 Uses of interleukin-4 and method for purifying it |
| 04/04/1991 | CA2066716A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 04/03/1991 | EP0420762A2 Heterocyclic compounds having lipoxygenase inhibiting activity |
| 04/03/1991 | EP0420571A2 6-and/or 7-substituted -1,2,3,4,4A,9B-hexahydro-8-hydroxydibenzofuran-3-ols as inhibitors of leukotriene biosynthesis |
| 04/03/1991 | EP0420570A2 Trans 2,3-disubstituted-2,3-dihydro-5-hydroxy-benzofurans as inhibitors of leukotriene biosynthesis |
| 04/03/1991 | EP0420511A2 Heterocyclic derivatives |
| 04/03/1991 | EP0420049A1 Stabilized leucocyte-interferon |
| 04/03/1991 | EP0419998A2 Use of alkylphosphonic acid derivatives for the treatment of psoriasis |
| 04/03/1991 | EP0419861A2 Use of dibenz[b,f][1,4]oxazepin (and thiazepin)-11(10H)-ones and -thiones in the preparation of a pharmaceutical composition for the prevention or treatment of aids |
| 04/03/1991 | EP0419610A1 New leukotriene b4 derivatives, process for producing them and their use as drugs. |
| 04/03/1991 | CN1050385A Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity |
| 04/03/1991 | CN1050384A Substituted dibenzofurans and methods of using same |
| 04/03/1991 | CN1050381A Substituted isoquinolines and methods of using same |
| 04/02/1991 | US5004748 Enzyme inhibitors, immunosuppresants; for controlling collagen metabolism |
| 04/02/1991 | US5004743 Antiinflammatory, cytoprotective agents |
| 04/02/1991 | US5004742 Benzothiazine-1,1-dioxide derivatives |
| 04/02/1991 | US5004692 Pure DNA segment for producing large quantities of clostridium phospholipase polypeptides |
| 04/02/1991 | US5004681 Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
| 03/30/1991 | CA2026227A1 Heterocyclic compound |
| 03/30/1991 | CA2025155A1 Extracellular exopolymer, process for its preparation and pharmaceutical compositions containing the said exopolymer |
| 03/30/1991 | CA2024258A1 Heterocyclic derivatives |
| 03/29/1991 | CA2024046A1 Stabilized leukocyte-interferons |
| 03/27/1991 | EP0419411A2 Additional alkanophenones |
| 03/27/1991 | EP0419410A2 Alkanophenones |
| 03/27/1991 | EP0419210A1 Novel benzimidazole compounds and their use |
| 03/27/1991 | EP0419132A2 Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 03/27/1991 | EP0419131A2 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 03/27/1991 | EP0419091A1 Interleukin-4 receptors |
| 03/27/1991 | EP0419049A1 (Quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 03/27/1991 | EP0418797A2 Pyrimidin-4,6-dicarboxilic acid diamides, process for their preparation also medicine based on those compounds |
| 03/27/1991 | EP0418564A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content |
| 03/27/1991 | CN1050192A Process for preparating antiviral tetrahydroimidazo (1,4) benzodiazepines |
| 03/27/1991 | CN1050190A Process for preparing sulphamoylthiophenes |
| 03/26/1991 | US5002966 Adrenergic Stimulants |
| 03/26/1991 | US5002869 Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes |
| 03/26/1991 | CA2025479A1 6-and/or 7-substituted-1,2,3,4,4a 9b-hexahydro-8-hydroxydibenzofuran-3-ols as inhibitors of leukotriene biosynthesis |
| 03/26/1991 | CA2025478A1 Trans 2,3-disubstituted-2,3-dihydro-5-hydroxybenzofurans as inhibitors of leukotriene biosynthesis |
| 03/23/1991 | WO1991004269A1 Medicament comprising antamanide |
| 03/23/1991 | CA2066721A1 Medicament comprising antamanide |
| 03/23/1991 | CA2025849A1 Benzimidazole compounds and their use |
| 03/22/1991 | WO1991004058A2 Treatment of conditions and disease |
| 03/22/1991 | CA2042034A1 Treatment of conditions and disease |
| 03/22/1991 | CA2025799A1 Pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation and the use thereof, and pharmaceuticals based on these compounds |
| 03/21/1991 | WO1991004259A1 Lipid a monosaccharide analog |
| 03/21/1991 | WO1991003556A1 Recombinant product |
| 03/21/1991 | WO1991003495A1 Method for producing soluble glucans |
| 03/21/1991 | WO1991003252A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
| 03/21/1991 | WO1991003244A1 Composition for percutaneous administration |